Characterization and Treatment of Chemotherapy Neuropathy (CIN)
Characterization of and Treatment for Chemotherapy-Induced Neuropathy
Sponsor: University of California, San Francisco
Listed as NCT01557608, this NA trial focuses on Chemotherapy-induced Neuropathy and remains completed. Sponsored by University of California, San Francisco, it has been updated 8 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
Status: Unknown Status → Completed · Phase: PHASE2 → NA
-
Jun 2018 — Feb 2020 [monthly]
Unknown Status PHASE2
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status PHASE2
Status: Active Not Recruiting → Unknown Status
-
Feb 2017 — Apr 2018 [monthly]
Active Not Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE2
First recorded
Apr 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .